AFPᶜ³³²T in Advanced HCC
NCT03132792
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Cancer
AFP Expressing Tumors
Interventions
GENETIC:
Autologous genetically modified AFPᶜ³³²T cells
Sponsor
Adaptimmune